Good quality white‐light transurethral resection of bladder tumours (GQ‐WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non‐muscle‐invasive bladder cancer: validation across time and place and recommendation for benchmar

Study Type – Therapy (cohort)

[1]  C. Dubeau,et al.  The evaluation and treatment of nocturia: a consensus statement , 2011, BJU international.

[2]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. , 2011, European urology.

[3]  G. Dalbagni.  Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. , 2010, European urology.

[4]  M. Soloway,et al.  "Complete transurethral resection of bladder tumor": are the guidelines being followed? , 2010, Urology.

[5]  M. Babjuk,et al.  Transurethral Resection of Non–muscle-invasive Bladder Cancer , 2009 .

[6]  H. Herr,et al.  Quality control in transurethral resection of bladder tumours , 2008, BJU international.

[7]  J. Whiteway,et al.  COMPLETENESS OF FIRST RESECTION OF BLADDER TUMOUR DEPENDING ON SENIORITY OF THE SURGEON , 2008 .

[8]  M. Viola,et al.  DEDICATED TEACHING PROGRAMS CAN IMPROVE THE QUALITY OF TUR OF NON-MUSCLE-INVASIVE BLADDER TUMOURS (NMIBT): EXPERIENCE OF A SINGLE INSTITUTION , 2008 .

[9]  K. Grigor,et al.  Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades. , 2007, The Journal of urology.

[10]  M. Manoharan.  Optimal Management of the T 1 G 3 Bladder Cancer , 2007 .

[11]  H. Herr,et al.  A re‐staging transurethral resection predicts early progression of superficial bladder cancer , 2006, BJU international.

[12]  M. Babjuk,et al.  Guidelines on TaT 1 ( Non-muscle invasive ) Bladder Cancer , 2006 .

[13]  H. Woo,et al.  Management of stage T1 tumors of the bladder: International Consensus Panel. , 2005, Urology.

[14]  A. Unsal,et al.  The actual incidence of bladder perforation following transurethral bladder surgery. , 2005, The Journal of urology.

[15]  A. Papatsoris,et al.  Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence? , 2005, The Journal of urology.

[16]  M. Soloway,et al.  Optimal management of the T1G3 bladder cancer. , 2005, The Urologic clinics of North America.

[17]  P. Mariappan,et al.  A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. , 2005, The Journal of urology.

[18]  A. Bohle,et al.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. , 2004, International braz j urol : official journal of the Brazilian Society of Urology.

[19]  M. Grimm,et al.  Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. , 2003, The Journal of urology.

[20]  M. Peyromaure,et al.  The value of a second transurethral resection in evaluating patients with bladder tumours. , 2003, European urology.

[21]  V. Reuter,et al.  Impact of a second transurethral resection on the staging of T1 bladder cancer. , 2002, Urology.

[22]  D. Lamm,et al.  Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. , 2002, The Journal of urology.

[23]  W. Murphy,et al.  Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. , 2002, The Journal of urology.

[24]  Laurence Collette,et al.  Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. , 2002, European urology.

[25]  Gerhard Jakse,et al.  Guidelines on bladder cancer. , 2002, European urology.

[26]  Michael Cookson,et al.  Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. , 2001, The Journal of urology.

[27]  G. Jakse,et al.  Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? , 2001, The Journal of urology.

[28]  H. Herr,et al.  The value of a second transurethral resection in evaluating patients with bladder tumors. , 2000, The Journal of urology.